United States Unfractionated Heparin Market Report 2016

October 2016 | 122 pages | ID: UFBCD8EC1C3EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Unfractionated Heparin

Revenue, means the sales value of Unfractionated Heparin

This report studies sales (consumption) of Unfractionated Heparin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Unfractionated Heparin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Unfractionated Heparin Market Report 2016

1 UNFRACTIONATED HEPARIN OVERVIEW

1.1 Product Overview and Scope of Unfractionated Heparin
1.2 Classification of Unfractionated Heparin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Unfractionated Heparin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Unfractionated Heparin (2011-2021)
  1.4.1 United States Unfractionated Heparin Sales and Growth Rate (2011-2021)
  1.4.2 United States Unfractionated Heparin Revenue and Growth Rate (2011-2021)

2 UNITED STATES UNFRACTIONATED HEPARIN COMPETITION BY MANUFACTURERS

2.1 United States Unfractionated Heparin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Unfractionated Heparin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Unfractionated Heparin Average Price by Manufactures (2015 and 2016)
2.4 Unfractionated Heparin Market Competitive Situation and Trends
  2.4.1 Unfractionated Heparin Market Concentration Rate
  2.4.2 Unfractionated Heparin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES UNFRACTIONATED HEPARIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Unfractionated Heparin Sales and Market Share by Type (2011-2016)
3.2 United States Unfractionated Heparin Revenue and Market Share by Type (2011-2016)
3.3 United States Unfractionated Heparin Price by Type (2011-2016)
3.4 United States Unfractionated Heparin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES UNFRACTIONATED HEPARIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Unfractionated Heparin Sales and Market Share by Application (2011-2016)
4.2 United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES UNFRACTIONATED HEPARIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Unfractionated Heparin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Unfractionated Heparin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Unfractionated Heparin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Unfractionated Heparin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Unfractionated Heparin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Unfractionated Heparin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Unfractionated Heparin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Unfractionated Heparin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Unfractionated Heparin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Unfractionated Heparin Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 UNFRACTIONATED HEPARIN MANUFACTURING COST ANALYSIS

6.1 Unfractionated Heparin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Unfractionated Heparin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Unfractionated Heparin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Unfractionated Heparin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES UNFRACTIONATED HEPARIN MARKET FORECAST (2016-2021)

10.1 United States Unfractionated Heparin Sales, Revenue Forecast (2016-2021)
10.2 United States Unfractionated Heparin Sales Forecast by Type (2016-2021)
10.3 United States Unfractionated Heparin Sales Forecast by Application (2016-2021)
10.4 Unfractionated Heparin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Unfractionated Heparin
Table Classification of Unfractionated Heparin
Figure United States Sales Market Share of Unfractionated Heparin by Type in 2015
Table Application of Unfractionated Heparin
Figure United States Sales Market Share of Unfractionated Heparin by Application in 2015
Figure United States Unfractionated Heparin Sales and Growth Rate (2011-2021)
Figure United States Unfractionated Heparin Revenue and Growth Rate (2011-2021)
Table United States Unfractionated Heparin Sales of Key Manufacturers (2015 and 2016)
Table United States Unfractionated Heparin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Unfractionated Heparin Sales Share by Manufacturers
Figure 2016 Unfractionated Heparin Sales Share by Manufacturers
Table United States Unfractionated Heparin Revenue by Manufacturers (2015 and 2016)
Table United States Unfractionated Heparin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Unfractionated Heparin Revenue Share by Manufacturers
Table 2016 United States Unfractionated Heparin Revenue Share by Manufacturers
Table United States Market Unfractionated Heparin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Unfractionated Heparin Average Price of Key Manufacturers in 2015
Figure Unfractionated Heparin Market Share of Top 3 Manufacturers
Figure Unfractionated Heparin Market Share of Top 5 Manufacturers
Table United States Unfractionated Heparin Sales by Type (2011-2016)
Table United States Unfractionated Heparin Sales Share by Type (2011-2016)
Figure United States Unfractionated Heparin Sales Market Share by Type in 2015
Table United States Unfractionated Heparin Revenue and Market Share by Type (2011-2016)
Table United States Unfractionated Heparin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Unfractionated Heparin by Type (2011-2016)
Table United States Unfractionated Heparin Price by Type (2011-2016)
Figure United States Unfractionated Heparin Sales Growth Rate by Type (2011-2016)
Table United States Unfractionated Heparin Sales by Application (2011-2016)
Table United States Unfractionated Heparin Sales Market Share by Application (2011-2016)
Figure United States Unfractionated Heparin Sales Market Share by Application in 2015
Table United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
Figure United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Unfractionated Heparin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Unfractionated Heparin Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Unfractionated Heparin Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Unfractionated Heparin Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Unfractionated Heparin Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Unfractionated Heparin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Unfractionated Heparin
Figure Manufacturing Process Analysis of Unfractionated Heparin
Figure Unfractionated Heparin Industrial Chain Analysis
Table Raw Materials Sources of Unfractionated Heparin Major Manufacturers in 2015
Table Major Buyers of Unfractionated Heparin
Table Distributors/Traders List
Figure United States Unfractionated Heparin Production and Growth Rate Forecast (2016-2021)
Figure United States Unfractionated Heparin Revenue and Growth Rate Forecast (2016-2021)
Table United States Unfractionated Heparin Production Forecast by Type (2016-2021)
Table United States Unfractionated Heparin Consumption Forecast by Application (2016-2021)